Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.610
+0.280 (6.47%)
May 28, 2026, 9:28 AM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.96 billion as of May 27, 2026. Its market cap has decreased by -4.67% in one year.
Market Cap
7.96B
Enterprise Value
8.05B
Revenue
1.04B
Ranking
n/a
PE Ratio
26.61
Stock Price
4.61
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.96B, a decrease of -32.80%. That is a compound annual growth rate of -8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 7.81B | -12.88% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 12.76B |
| Everest Medicines | 11.17B |
| HBM Holdings | 10.54B |
| CARsgen Therapeutics Holdings | 9.43B |
| Alphamab Oncology | 9.06B |
| Shanghai Haohai Biological Technology | 8.35B |
| Shanghai Bao Pharmaceuticals | 7.99B |
| Abbisko Cayman | 7.34B |